Cannabinoids Meet Gum, AXIM Joins with KISS

Some cannabis concerns are more imaginative than others.

New York-based AXIM Biotechnologies, Inc. (OTC:AXIM), a world leader in cannabinoid research and product development proved it Tuesday by telling investors it’s signed a multi-term agreement with Colorado-based gum developer KISS Industries, LLC, makers of CONFADENT Sugar-Free Chewing Gum.

The agreement grants KISS Industries a non-exclusive license to formulate and sell products that fall within AXIM’s patent on chewing gum containing cannabinoids and grants AXIM the ability to acquire 10% of KISS Industries.

Said CEO John Huemoeller, "As we focus on building revenue from our growing nutraceutical division, we understand the importance of maintaining AXIM’s reputation for providing high-quality full-spectrum hemp cannabidiol (CBD) products. KISS Industries will increase our capacity and sales channels through its distribution."

Shares in AXIM took on five cents, or 6.3%, to 86 cents, on volume of 49,000 shares.